模块化 γδ TCR-T 平台:结合 KRAS pMHC 靶向与可重复给药 mRNA 衔接器重定向
A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.
92.5分
★★★★★
站内排序·非疗效
ALL SOURCES
A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.
Top advances of the year in autologous cellular therapy in melanoma and solid tumors.
Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics.
Adopting tomorrow's therapies today: a perspective review of adoptive cell therapy in lung cancer.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。